01.06.2017 • News • Elaine Burridge • Lanxess • Berkshire Hathaway

Warren Buffett Takes Stake in Lanxess

(c) Lanxess
(c) Lanxess

Berkshire Hathaway, the conglomerate headed by American billionaire Warren Buffett, has taken a 3% stake in Germany’s Lanxess. A statement filed with the Frankfurt stock exchange on May 29 said Berkshire Hathaway subsidiary General Reinsurance purchased the stake on May 19. The move puts the US investor among the company’s top six shareholders.

Bloomberg news agency said Berkshire Hathaway has been pursuing investments in Germany and had agreed earlier this year to buy Wilhelm Schulz, a manufacturer of piping components based in Krefeld. The Omaha, Nebraska-headquartered holding group also owns 100% of US specialty chemicals company, Lubrizol.

Lanxess finalized last month its $2.4 billion purchase of US specialty chemicals producer, Chemtura, a move which boosts the German group’s annual turnover to €9.2 billion. Chemtura will be known as Lanxess Solutions US.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Top-Feature

most read